The Heart Under the Beam
An echocardiogram uses high-frequency diagnostic ultrasound directed at the heart — typically 30 to 60 minutes of continuous imaging. It is called non-invasive, which refers to the absence of a surgical incision. What the word does not describe is the acoustic energy being delivered to cardiac tissue for the duration of the exam.
Standard echocardiography uses multiple ultrasound modes in sequence: B-mode (2D structural imaging), M-mode (motion tracking), pulsed-wave Doppler, continuous-wave Doppler, and color flow Doppler mapping. Doppler modes — which assess valve function and blood flow — operate at significantly higher acoustic output and Thermal Index than standard imaging. A full echocardiogram accumulates substantially more acoustic energy than a brief prenatal heartbeat check or a 10-minute abdominal scan.
Myocardial Stunning
Myocardial stunning is a documented reduction in cardiac contractility following a stressor to the heart — temporary in many cases, but sometimes persistent. It appears in cardiology literature as an outcome of echocardiographic procedures, particularly stress echo. The mechanism: acoustic energy and/or pharmacological stress cause transient ischemia or direct cellular disruption at the myocardial level, impairing the heart's ability to contract fully beyond the duration of the examination.
Who Is Most Vulnerable
- • Patients referred for echo almost always have pre-existing cardiac concerns — reduced ejection fraction, valve disease, arrhythmia, post-MI evaluation. A heart already operating at reduced capacity has less reserve to absorb additional acoustic stress.
- • The population most frequently receiving extended echocardiographic imaging is the population least able to tolerate the additional myocardial burden it delivers.
- • Documented reductions in ejection fraction following echocardiography — including standard non-stress echo — appear in cardiology literature. This is not discussed at consent.
- • Repeat echocardiograms are standard for monitoring heart failure, post-surgical recovery, and valve disease — cumulative exposure accumulates across years, never assessed as a total protocol.
The Physics of Cardiac Tissue
- • The heart is highly metabolically active with a dense vascular supply — both conditions increase thermal absorption from acoustic energy. Coronary arteries deliver blood continuously; acoustic streaming effects influence blood flow dynamics at the capillary level.
- • High Intensity Focused Ultrasound (HIFU) already ablates cardiac arrhythmia pathways non-surgically — using the same acoustic mechanism at higher intensity. The same technology that destroys cardiac tissue at therapeutic levels is applied at lower intensity during diagnostic echo. The dial analogy: diagnostic and therapeutic ultrasound are on the same dial. The intensity differs. The mechanism does not.
- • The Thermal Index (TI) and Mechanical Index (MI) are displayed on every echocardiography machine. They are almost never explained to the patient.
Stress Echocardiogram — A Pharmacological Insult Added
A stress echocardiogram adds either exercise (treadmill or bike) or pharmacological stress to a standard echo. The most common pharmacological agent is dobutamine — a synthetic catecholamine that forces the heart to contract harder and faster, simulating vigorous exercise in a patient who is sedentary and often too unwell to exercise.
Dobutamine — What the Drug Actually Does
- • Dobutamine is a beta-1 adrenergic agonist. It forces heart rate up to 85% of maximum predicted rate and drives contractility beyond what the heart would produce voluntarily. In a patient with compromised coronary circulation, the forced demand can exceed supply — inducing ischemia in tissue that is already borderline.
- • Documented risks during dobutamine stress echo (in medical literature and the dobutamine package insert): ventricular arrhythmias, atrial fibrillation, serious hypotension, acute myocardial infarction, cardiac rupture, and death.
- • The procedure stacks three simultaneous insults: (1) dobutamine-forced increase in cardiac workload, (2) sustained echocardiographic Doppler during peak stress, and (3) continued imaging during recovery. All three phases occur in the same session. Patients consent to the drug risk but rarely receive separate discussion of what the acoustic component is doing to the same tissue.
- • Exercise stress echo carries different risks but identical acoustic exposure: at peak exercise, cardiac output increases four to five times above resting — dramatically altering hemodynamics and tissue perfusion at the exact moment of maximum Doppler imaging. The myocardium is most metabolically active and most vulnerable at precisely the time of greatest acoustic output.
The Contradiction at the Center
If the heart is strong enough to exercise to peak capacity, why is the stress echo necessary? If it is not strong enough — if that is the clinical question — why are we adding a pharmacological agent that forces it to perform as though it were? The procedure is designed for diagnostic utility. The question of what the diagnostic process costs the organ being examined is not part of the consent conversation.
Transesophageal Echocardiogram (TEE)
A transesophageal echo places the ultrasound transducer inside the esophagus — immediately adjacent to the posterior wall of the heart — to obtain higher-resolution images of cardiac structure. The proximity eliminates chest wall attenuation, which also means acoustic energy reaches the heart with minimal reduction. TEE is used for surgical guidance, atrial fibrillation ablation planning, and assessment of cardiac masses and valve disease.
Procedural Risks Not Related to Ultrasound
- • Esophageal perforation (rare but documented)
- • Dental and lip injury from probe insertion
- • Aspiration if sedation is incomplete
- • Laryngospasm and respiratory complications
- • Bacteremia from GI tract flora
- • Adverse reactions to conscious sedation agents
Acoustic Proximity Risk
- • Zero tissue attenuation between transducer and posterior cardiac wall means the thermal and mechanical index values apply at full intensity to cardiac tissue
- • Duration is typically 30–90 minutes
- • Frequently combined with sedation, reducing patient's ability to report symptoms during the procedure
- • Often used in patients who are already hemodynamically unstable — the highest-risk population
Cardiac Catheterization & Coronary Angiogram — Contrast in a Failing Kidney
A coronary angiogram (cardiac catheterization) is an invasive procedure in which a catheter is threaded into the coronary arteries and iodinated contrast dye is injected directly into the vessels so they can be visualized under fluoroscopic X-ray. It is used to assess blockages, plan stent placement, and evaluate coronary artery disease. It is routinely described as "standard" — a word that functions, in clinical practice, to close the conversation rather than open it.
What Iodinated Contrast Does to a Kidney That Cannot Function
- • Iodinated contrast agents are directly nephrotoxic. In patients with normal renal function, the contrast is filtered and excreted within hours. In patients with existing renal impairment, that clearance does not happen. The contrast remains in circulation, continuing to damage renal tubular cells with each pass.
- • Contrast-induced acute kidney injury (CI-AKI) is one of the most well-documented iatrogenic injuries in medicine — the third leading cause of hospital-acquired kidney failure. The risk is not linear: in established renal failure, it is not a question of whether injury occurs but of how much, and whether the kidneys recover function they had before the procedure.
- • The osmotic load problem: Iodinated contrast is hyperosmolar. In a patient whose kidneys cannot excrete the fluid burden, the osmotic load drives fluid from the vascular space into interstitial tissue throughout the body. The heart — already under pressure from renal disease — must pump against that expanded volume. If cardiac reserve is limited, acute decompensation follows.
- • NT-proBNP (N-terminal pro-B-type natriuretic peptide) is released by the ventricles in response to myocardial wall stress. A value of 300 pg/mL indicates some cardiac strain. A value of 45,000 pg/mL is catastrophic acute decompensation — the ventricle is under pressure so extreme that it is releasing distress hormones at 150 times the previous baseline. That is not a laboratory fluctuation. That is the body reporting that the heart is in crisis.
"It's Standard" Is Not Informed Consent
A patient who declines contrast and is told "it's standard" has not given informed consent. They have been overruled. The word "standard" in clinical communication functions as a conversation-ender — it positions the provider's protocol as a fact of nature rather than a risk-laden decision that can be accepted or refused. Standard of care establishes what is typically done. It does not eliminate the patient's right to know what that thing does to their body, or to say no.
For a patient in kidney failure, contrast administration is a known, documented, quantifiable risk — not a bureaucratic formality. The decision to proceed despite a patient's stated objection is not clinical judgment. It is the substitution of the provider's preference for the patient's decision-making authority over their own body.
Additional Contrast-Related Risks Not Routinely Disclosed
- • Allergic and anaphylactic reactions — ranging from urticaria to cardiovascular collapse; history of prior contrast reaction dramatically elevates risk
- • Contrast-induced thyrotoxicosis — iodine load can precipitate thyroid storm in patients with undiagnosed hyperthyroidism or nodular thyroid disease
- • Procedural complications independent of contrast: arterial dissection at catheter entry site, coronary spasm induced by guidewire, cholesterol embolism, stroke from air or plaque emboli, arrhythmia, and hematoma at the femoral or radial access site
- • Radiation exposure: fluoroscopic cardiac catheterization delivers substantially higher radiation dose than a chest X-ray — in complex or prolonged procedures, dose can approach CT-level exposure to thoracic and abdominal organs
Abdominal Ultrasound — The Liver and What It Absorbs
Abdominal ultrasound is among the most commonly performed diagnostic procedures: fatty liver disease, gallstones, liver lesions, portal hypertension, kidney surveillance, pancreatic masses. A full abdominal exam runs 30 to 45 minutes. Portal vein Doppler — added when blood flow assessment is needed — applies the highest-output mode of the examination to hepatic tissue that is often already metabolically compromised.
The same two mechanisms that apply to prenatal and cardiac ultrasound apply here: thermal heating (Thermal Index) and acoustic cavitation (Mechanical Index). The liver's dense vascular architecture — hepatic artery, portal vein, hepatic veins — creates concentrated acoustic absorption at vessel walls and tissue interfaces throughout the exam.
The Liver: Highest Thermal Absorption
HIFU and the Liver
- • Hepatic tissue is a primary target for High Intensity Focused Ultrasound (HIFU) tumor ablation — precisely because it absorbs and converts acoustic energy efficiently. The same tissue absorptivity that makes HIFU effective for destroying liver tumors is present during every diagnostic abdominal ultrasound at lower intensity.
- • HIFU liver ablation and diagnostic liver ultrasound are not different technologies. They are the same acoustic mechanism applied at different points on the intensity scale.
- • Patients undergoing monitoring for NAFLD, cirrhosis, or hepatic fibrosis may receive biannual abdominal ultrasound for years. The cumulative exposure to compromised liver tissue has not been studied as a serial protocol. Each scan is evaluated in isolation.
Portal Vein Doppler
- • Portal Doppler is the highest-acoustic-output component of abdominal ultrasound — and it is applied to patients whose liver is already compromised by disease. Portal hypertension patients have altered tissue density, abnormal vascular resistance, and reduced hepatic reserve. Acoustic energy is delivered to structurally and functionally impaired tissue.
- • TI and MI readings during portal Doppler are not shown or explained to the patient.
- • The informed consent for abdominal ultrasound does not include discussion of biological mechanisms — thermal or cavitation — for any component of the examination.
Kidney, Gallbladder & Pancreatic Ultrasound
Renal ultrasound for kidney stone surveillance, chronic kidney disease monitoring, or mass evaluation applies extended acoustic exposure to organs that — in the populations most likely to need this imaging — are already functionally impaired. Kidneys filter approximately 180 liters of blood per day; the renal cortex and medulla are highly vascular. Acoustic streaming effects on renal microcirculation have not been evaluated as a clinical concern.
Gallbladder and pancreatic ultrasound are typically shorter procedures but are often repeated over diagnostic workups for abdominal pain, biliary disease, or pancreatic lesion surveillance. The pancreas sits posterior to the stomach and requires transducer pressure and extended dwell times for adequate visualization — increasing both duration and tissue contact intensity.
The Cumulative Protocol That Doesn't Exist
A patient with metabolic syndrome may receive: annual liver ultrasound for NAFLD, periodic renal ultrasound for kidney function, occasional gallbladder assessment, and cardiac echo for cardiovascular risk — all within the same healthcare system, from different departments, with no one tracking total lifetime abdominal or cardiac acoustic exposure. The cumulative load is not discussed. It is not even measured.
Ionizing Radiation — A Different Mechanism, the Same Consent Gap
CT scans and X-rays use ionizing radiation — electromagnetic energy at frequencies high enough to remove electrons from atoms and break chemical bonds, including DNA strands. This is categorically different from the mechanical acoustic energy of ultrasound. The biological effects are also different: direct DNA damage, free radical generation, and increased cancer risk that accumulates with every exposure. Unlike acoustic exposure, there is no threshold below which ionizing radiation has zero biological effect — the dose-response relationship is assumed to be linear.
CT Scan — What the Numbers Actually Mean
Radiation Dose Comparisons
- • Chest X-ray: ~0.1 mSv — equivalent to approximately 10 days of natural background radiation
- • CT abdomen/pelvis: ~10 mSv — equivalent to approximately 3 years of background radiation in a single scan
- • CT chest: ~7 mSv
- • CT head: ~2 mSv
- • Cardiac CT angiography: 5–15 mSv depending on protocol
- • PET-CT (full body): 25 mSv — equivalent to 8+ years of natural background radiation
- • Effective dose estimates vary significantly by scanner, protocol, and patient size — the numbers above are approximations from standard reference ranges.
Cancer Risk — What the Evidence Shows
- • A landmark 2007 study in the New England Journal of Medicine (Brenner & Hall) estimated that 1.5–2% of all cancers in the United States could be attributable to CT scans.
- • The risk is higher for children (longer expected lifespan, greater cell proliferation rate) and for scans of radiosensitive organs: breast, thyroid, gonads, bone marrow.
- • Contrast-enhanced CT adds gadolinium or iodine-based agents — with their own separate documented adverse event profiles (see the pharmacology library for contrast agent entries).
- • Serial CT scanning — increasingly common for cancer surveillance, inflammatory bowel disease monitoring, and trauma follow-up — accumulates radiation dose that has never been formally assessed as a total lifetime protocol in individual patients.
The Problem of Incidental Findings
CT scans frequently reveal "incidentalomas" — incidental findings that were not the reason for the scan and may be entirely benign. Standard protocol is to follow up with additional imaging. A single CT for an acute complaint can initiate a cascade of follow-up scans that collectively deliver many times the original radiation exposure — with each scan justified by the finding of the previous one. The original informed consent for the first scan never included this cascading exposure possibility.
Mammography — Radiation to Radiosensitive Tissue
Mammography uses low-energy X-rays — approximately 0.4 mSv per standard bilateral exam — directed at breast tissue, which is among the most radiosensitive tissue in the body. Annual screening beginning at age 40 means decades of cumulative breast radiation. The compression force applied during mammography (typically 130–200 newtons, up to 45 lbs of pressure) flattens and stresses glandular tissue. Neither the radiation exposure nor the mechanical compression is discussed in detail at consent.
What the Evidence Shows on Screening
A 2014 analysis in the BMJ (Miller et al., Canadian National Breast Screening Study — 25-year follow-up) found no reduction in breast cancer mortality from annual mammography screening compared to physical examination alone, while documenting significant overdiagnosis. A 2012 NEJM analysis estimated 1.3 million women were overdiagnosed with breast cancer in the US over a 30-year period — treated for cancers that would never have caused symptoms or death. These findings are not standard consent disclosure.
Radiation-Induced Breast Cancer Risk
- • Women with BRCA1/2 mutations are significantly more radiosensitive — mammography screening in this population may increase rather than decrease lifetime breast cancer risk
- • The dose from a single mammogram is small; the clinical concern is cumulative annual exposure over 20–30 years of screening
- • MRI (no ionizing radiation) is recommended over mammography for high-risk women — a risk stratification that is rarely applied in standard screening
Procedures Nobody Frames as Risk Events
The following procedures are routinely presented as low-risk or risk-free. Each has documented biological mechanisms and adverse event profiles. The consent conversation for each is typically focused on immediate procedural complications — perforation, bleeding, adverse drug reaction — rather than on what the procedure does to the tissue, organ, or system being examined over time.
Colonoscopy
Colonoscopy is the standard colorectal cancer screening procedure. It is presented as a preventive intervention. The documented risks include bowel perforation (approximately 1 in 1,000), post-polypectomy bleeding, splenic injury from scope traction, cardiovascular events from sedation, and post-procedure infection. A 2006 study in Gastroenterology found that the post-colonoscopy period carries elevated risk of emergency hospitalization — primarily from perforations and cardiovascular events — that is not reflected in the summary statistics used in benefit discussions.
The Bowel Prep Problem
- • Standard bowel prep (polyethylene glycol or sodium picosulfate solutions) flushes the intestinal microbiome with each colonoscopy. Microbiome disruption from prep has been documented to persist weeks to months post-procedure.
- • In patients with compromised gut function, IBD, or microbiome-dependent conditions, this disruption may be clinically significant and is not discussed at consent.
- • Patients on anticoagulants must stop them for colonoscopy — the bridging protocol carries its own cardiovascular risk window.
Sedation and the Cardiovascular Window
- • Colonoscopy typically uses propofol or midazolam/fentanyl for conscious sedation. Both suppress respiratory drive and cardiovascular reflexes.
- • Cardiac events — including MI and arrhythmia — during colonoscopy are documented, particularly in patients over 65 with pre-existing cardiac disease.
- • Air insufflation used to expand the colon creates intraluminal pressure that can trigger vasovagal responses and affect heart rate and blood pressure throughout the procedure.
The Alternative That Is Rarely Offered
Fecal immunochemical testing (FIT) — a non-invasive stool test — has been shown in multiple European studies to reduce colorectal cancer mortality with significantly lower complication risk than colonoscopy. It is not the default in the US screening model. The colonoscopy-first approach is standard of care, and alternatives are rarely discussed as equivalent options at consent.
Thyroid, Carotid & Reproductive Ultrasound
Thyroid Ultrasound
The thyroid is a superficial endocrine gland — the transducer sits directly over it with minimal tissue between the probe and gland. High-frequency transducers (12–18 MHz) provide maximum resolution but also higher energy deposition per unit area. Patients with thyroid nodules under surveillance may receive annual or more frequent imaging for years. Long-term biological effects of repeated high-frequency acoustic exposure on thyroid follicular cells have not been studied prospectively.
Carotid Doppler
Doppler assessment of the carotid arteries evaluates atherosclerotic plaque and blood flow velocity. High-output Doppler is applied directly to vessel walls that — in the target population — already have compromised endothelial integrity. Acoustic streaming effects on fragile atherosclerotic plaque have not been evaluated as a clinical risk factor. In a vessel supplying the brain, plaque disruption is not a theoretical concern.
Testicular Ultrasound
Testicular ultrasound is used for varicocele assessment, mass evaluation, and fertility workup. Sperm production requires a temperature 2–4°C below core body temperature — which is why the testes are located outside the body. The thermal effects of diagnostic ultrasound on spermatogonial stem cells and sperm motility have not been studied in the context of male fertility evaluation — the clinical indication for which many of these scans are ordered.
Pelvic & Transvaginal Ultrasound
Transvaginal ultrasound for ovarian monitoring, follicle tracking in fertility treatment, or endometrial assessment places the transducer in direct contact with pelvic organs with no tissue attenuation. Women undergoing IVF egg retrieval may receive multiple transvaginal scans per cycle across multiple cycles. The acoustic exposure to maturing oocytes and follicular tissue during the most sensitive phase of reproductive development has not been studied as a clinical concern in fertility protocols.
MRI — A Massive Electromagnetic Dose
The standard framing that MRI is safe because it uses "no ionizing radiation" is incomplete. MRI is a large electromagnetic exposure delivered to the entire body simultaneously through three distinct fields operating at the same time — and the biological effects of that combined exposure are not what most patients are told before they sign consent.
Three Simultaneous Electromagnetic Exposures
- • Static magnetic field (1.5T–3T): Standard clinical MRI operates at 1.5 to 3 Tesla — 30,000 to 60,000 times the strength of Earth's natural magnetic field. High-field research MRIs reach 7T or beyond. Your entire body is immersed in this field for the duration of the scan.
- • Gradient switching fields: Rapidly switching magnetic fields are pulsed throughout the scan to create spatial resolution. These changing fields induce electrical currents in tissue — which is what generates the loud mechanical noise and can produce peripheral nerve stimulation.
- • Radiofrequency (RF) pulses: RF energy at precise frequencies is used to excite hydrogen nuclei. This energy is absorbed by tissue as heat — measured as Specific Absorption Rate (SAR). The RF component causes measurable, organ-specific tissue heating.
Magnetic Field Exposure and DNA Damage
Static and gradient magnetic fields at clinical MRI intensities have been documented to cause DNA double-strand breaks and micronuclei formation in human blood cells. Critically, research has shown these genotoxic effects can persist for up to 30 days following a single MRI scan — the body does not immediately clear the damage caused by the magnetic exposure.
The claim that MRI is safe because it is "non-ionizing" does not address this mechanism. Non-ionizing electromagnetic fields at sufficient intensity have documented genotoxic effects that are distinct from the ionizing/non-ionizing framing used in conventional radiology risk communication. This is not discussed at consent.
Gadolinium Contrast Retention
Gadolinium-based contrast agents (GBCAs) used in contrast MRI have been documented to deposit in brain tissue, bone, and skin in patients with normal renal function — a phenomenon called Gadolinium Deposition Disease (GDD). The FDA issued a class warning in 2017. Retained gadolinium in the brain has been confirmed in autopsy studies of patients with no history of renal impairment. Long-term neurological effects are still being studied and are not discussed as a standard risk at consent.
Radiofrequency Heating & Implants
- • The RF component causes measurable tissue heating. Limits are applied, but heating is real and organ-specific.
- • Metallic implants (dental, orthopedic, cardiac devices) can concentrate RF energy into localized heating. Even MRI-conditional implants carry field-strength and pulse-sequence specifications that are not always reviewed before ordering.
- • MRI acoustic noise can reach 130 dB in some sequences — exceeding occupational noise standards for unprotected hearing. Ear protection is standard but adequacy across extended high-field scans is not formally studied.
What Informed Consent Would Actually Require
These questions apply to any diagnostic procedure. They are not designed to refuse — they are designed to make an actual decision rather than a reflexive consent. A provider who cannot answer them has not thought through the informed consent component of the procedure they are ordering.
Before Any Imaging Procedure
- • What is the specific clinical indication? What finding would change your clinical decision? If no finding would change management — if the scan is precautionary or for documentation — the risk-benefit calculation is different than if the finding would direct treatment.
- • Is there a lower-exposure alternative that would provide the needed information? FIT test instead of colonoscopy. MRI instead of CT. Laboratory assessment instead of serial imaging.
- • How does this scan interact with my full imaging history? What is my cumulative radiation dose? What organs have received repeated acoustic exposure? Do you have my imaging records from other providers?
- • What is the false positive rate for this procedure in my demographic and indication? What happens if there is an incidental finding — how many additional scans does that typically generate?
- • Can we wait? For non-urgent indications, is watchful waiting with symptom monitoring a reasonable alternative to immediate imaging?
Before an Echocardiogram or Cardiac Stress Test
- • What is my current ejection fraction and what level of change would alter your management? If the answer is "I want to establish a baseline," what is the plan once the baseline is established?
- • For stress echo specifically: What is the protocol if I develop arrhythmia or chest pain during the dobutamine infusion? Who is present and what equipment is immediately available?
- • How long will Doppler modes be running during the examination? Can standard imaging be completed with B-mode before Doppler is added?
- • What is the plan for follow-up? Will this echo initiate a series of repeat exams? Over what period and at what trigger points?
- • Are there symptoms I should monitor for in the 24–48 hours after the echo that might indicate myocardial stress from the procedure?
Before a CT Scan
- • What is my estimated radiation dose in mSv for this specific scan? How does that compare to annual background radiation?
- • Is contrast required? If so, what agent — and has gadolinium retention risk been discussed for brain MRI contrast? For iodine-based CT contrast: what is the protocol if I have a reaction?
- • Will this scan generate incidental findings that are likely to require follow-up imaging? What is the typical cascade from this type of scan in this clinical context?
- • Could MRI provide equivalent diagnostic information for this indication without ionizing radiation?
- • Is there a low-dose protocol available for this scan type? Iterative reconstruction CT protocols can reduce dose by 30–50% for equivalent image quality in many indications.
This page is educational. All content is drawn from published medical and scientific literature. The goal is not refusal of necessary diagnostic procedures — it is genuine informed consent, which requires understanding what the procedure does before you agree to it.
Video Transcript
Allie Johnson, DNM, DIM, PNM
The word "non-invasive" gets used a lot in diagnostic medicine. And what it technically means is: no incision. Nobody is cutting into you. But somewhere along the way, "non-invasive" became a synonym for "no effect" — and that is not the same thing at all.
Every diagnostic procedure delivers energy to your tissue. That's how it works. Ultrasound works by directing sound waves into the body and reading the echo. X-rays work by passing ionizing radiation through the body. MRI works by immersing your entire body in a magnetic field that is tens of thousands of times stronger than Earth's. CT works by rotating X-ray beams around you from multiple angles at once.
None of these are neutral. They are all doing something to the tissue they are examining. And in almost every case, the biological effects of that process are not part of the informed consent conversation before you agree to the procedure.
That's what I want to talk about today.
The Echocardiogram
Let's start with the echocardiogram, because this is one I see come up a lot — and one that has a very clear disconnect between how it's described and what it actually is.
An echocardiogram is 30 to 60 minutes of continuous high-frequency ultrasound directed at the heart. It uses multiple modes: structural 2D imaging, motion tracking, and Doppler — which is color flow mapping and valve assessment. That Doppler component runs at significantly higher acoustic output than the structural imaging. You're accumulating a lot of energy delivered to cardiac tissue over the course of that exam.
There is a phenomenon in the cardiology literature called myocardial stunning. It's a documented reduction in the heart's ability to contract following a stressor. It appears as an outcome of echocardiographic procedures — including standard echo, not just stress echo. The mechanism is acoustic energy and tissue disruption at the cellular level causing temporary — and sometimes not so temporary — reduction in contractile function. Ejection fraction drops. This is in the literature. It is not discussed at consent.
And here's what makes this particularly important: who gets echocardiograms? People with already-compromised cardiac function. Reduced ejection fraction, valve disease, post-heart-attack evaluation, heart failure monitoring. The population receiving the most acoustic exposure to the heart is the population with the least reserve to absorb additional stress to the heart. That is not a coincidence — that's the clinical indication. And the fact that the diagnostic process itself is a stressor to the organ being diagnosed is something patients deserve to know.
Stress Echo and Dobutamine
The stress echocardiogram takes this further. In a pharmacological stress echo, they give you a drug called dobutamine — a synthetic catecholamine that forces your heart to beat harder and faster, up to 85% of your maximum predicted heart rate, simulating vigorous exercise. The listed risks in the dobutamine package insert include ventricular arrhythmias, acute myocardial infarction, cardiac rupture, and death.
The intended paradox of this procedure is worth sitting with. If your heart is strong enough to reach 85% of maximum predicted heart rate, why do we need the stress echo? If it's not strong enough — if that is the clinical question — why are we forcing it to perform as though it were? And while that drug is working, extended Doppler imaging is running throughout. Three simultaneous insults on the same visit, in the same session.
There is a question that belongs in every stress echo consent conversation that is currently not there: what is the plan if the procedure itself causes injury? What happens to you in the 24 to 48 hours after? Are there symptoms you should watch for? Almost never discussed.
Cardiac Catheterization and Contrast
Now I want to talk about something that I have watched happen to patients, and it is the clearest example of why the word "standard" is not the same as "informed consent."
A cardiac catheterization — a coronary angiogram — involves threading a catheter into the coronary arteries and injecting iodinated contrast dye directly into those vessels under continuous fluoroscopic X-ray. The contrast dye allows the vessels to be visualized. And in a patient with normal kidney function, that contrast is filtered and excreted within a few hours.
In a patient in kidney failure, that does not happen. The contrast stays in circulation. It is directly nephrotoxic — it continues damaging renal tubular cells with each pass. Contrast-induced acute kidney injury is the third leading cause of hospital-acquired kidney failure. It is one of the most well-documented iatrogenic injuries in medicine. And on top of that, iodinated contrast is hyperosmolar — it pulls fluid out of the vascular space into the body's tissues. When the kidneys can't excrete that fluid burden, the volume backs up. The heart has to pump against it. If there is any cardiac compromise — which there is, because that's why the cath is being done — acute decompensation follows.
I know of a case where a patient said no to contrast. They were in kidney failure. They said — I don't want contrast. The provider said it was standard. The NT-proBNP — that's the marker that tells you how hard the ventricle is working, how much wall stress it's under — was 300 before the procedure. Afterward it was 45,000. That is 150 times the baseline. That is the heart in crisis. That is not a laboratory fluctuation. That is what a contrast load does to kidneys that cannot clear it, that then floods the tissues, that then drowns a heart that was already struggling.
Standard of care tells you what is typically done. It does not override a patient's right to understand what that thing does to their body and to say no. A patient who is overruled is not a patient who consented.
Abdominal Ultrasound and the Liver
The same acoustic mechanisms that apply to the heart apply to every organ that receives diagnostic ultrasound. The liver is actually one of the most absorptive tissues in the body for acoustic energy — which is exactly why High Intensity Focused Ultrasound is used to ablate liver tumors. HIFU destroys tissue by concentrating the same ultrasound mechanism at higher intensity. The dial analogy: diagnostic ultrasound and therapeutic ultrasound that destroys liver tumors are on the same dial. The intensity is different. The mechanism is not.
Patients with fatty liver disease, cirrhosis, or NAFLD may be getting biannual liver ultrasounds for years. Every scan in isolation looks fine. Nobody is looking at what 10 years of biannual acoustic exposure to already-compromised liver tissue looks like as a cumulative protocol. Because that study hasn't been done. And because it hasn't been done, the answer at consent is "it's safe."
CT Scans and Ionizing Radiation
CT scans and X-rays work by a completely different mechanism — ionizing radiation. This is electromagnetic energy at a frequency high enough to knock electrons off atoms and break chemical bonds, including DNA strands. There is no threshold below which this has zero biological effect. The relationship between dose and cancer risk is assumed to be linear — meaning every exposure adds to cumulative risk. The operating principle is not "this is safe." It is "the diagnostic benefit justifies the risk." Those are not the same thing, and only one of them belongs in a consent conversation.
A CT scan of the abdomen and pelvis delivers approximately 10 millisieverts of radiation — equivalent to about three years of natural background radiation in a single scan. A landmark 2007 paper in the New England Journal of Medicine estimated that one-and-a-half to two percent of all cancers in the United States may be attributable to CT scans. That paper was published almost 20 years ago, and CT use has increased substantially since then.
One of the mechanisms nobody talks about is the incidentaloma cascade. You get a CT for acute abdominal pain. The scan finds something incidental — a small nodule, an adrenal finding, a pulmonary shadow — that wasn't the reason for the scan. Protocol says follow up. Follow-up means another scan. That scan may find something else that needs follow-up. The original consent for that one emergency CT never included the possibility of a years-long imaging cascade that collectively delivers ten times the original exposure.
MRI — Not Nothing
The standard reassurance for MRI is that it uses no ionizing radiation. That is true. But MRI is not doing nothing. MRI is immersing your entire body in a magnetic field that at standard clinical strength is 30,000 to 60,000 times the strength of Earth's natural magnetic field. And it is doing this while simultaneously running rapidly-switching gradient magnetic fields that induce electrical currents in tissue — that's what makes the loud noise — and while pulsing radiofrequency energy into your body that heats your tissue. Three simultaneous electromagnetic exposures at once.
Research has documented that static and switching magnetic fields at clinical MRI intensity cause DNA double-strand breaks and micronuclei formation in human blood cells. And those genotoxic effects have been shown to persist for up to 30 days after a single scan. Your body doesn't immediately repair what a clinical MRI does to your DNA. "No ionizing radiation" is not the same as "no genotoxic effect." The mechanism is different. The effect is documented.
And then there is gadolinium. Gadolinium-based contrast agents used in contrast MRI have been confirmed — by autopsy studies, in patients with completely normal renal function — to deposit in the brain, in bone, in skin. The FDA issued a class warning about this in 2017. Gadolinium Deposition Disease is real. It is still being studied. It is not standard consent disclosure.
What Informed Consent Actually Looks Like
None of what I've shared here is a reason to refuse every diagnostic procedure. Sometimes these procedures are exactly the right tool. Sometimes the information they provide is genuinely necessary and the risk is genuinely worth it. That is what medicine should be able to tell you — not just the benefit, but the actual tradeoff.
What I'm asking you to do is stop treating the doctor's order as the end of the conversation and start treating it as the beginning. Before any imaging procedure, ask: what specific finding are you looking for, and what would you do differently if you found it? Is there a lower-exposure alternative? If this scan shows something incidental, what is the likely cascade? What is my cumulative imaging history?
If a provider can't answer those questions, they have not thought through the informed consent component of the procedure they are ordering. You are allowed to ask them to think it through before you agree.
Non-invasive means no incision. It does not mean no biological effect. Informed consent requires knowing the difference — before you agree, not after.